[Challenges in the surgical management of hearts with a functional single ventricle]

István Hartyánszky1, Zsolt Prodán, László Király

  • 1Gottsegen Györgyi Országos Kardiológiai Intézet, Gyermekszív Központ, Budapest. hartyanszky@hotmail.com

Orvosi Hetilap
|October 7, 2005
PubMed

Insights

High-risk bidirectional Glenn (BDG) and total cavopulmonary connection (TCPC) surgeries for complex congenital heart disease show encouraging early results. These procedures successfully manage previously contraindicated defects, improving ventricular function in the short to mid-term.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Congenital Heart Disease

Context:

  • Complex congenital heart diseases with single ventricle physiology present significant surgical challenges.
  • Bi-directional Glenn (BDG) and total cavopulmonary connection (TCPC) are established palliative procedures.
  • Certain complex cases were previously considered inoperable due to associated defects.

Purpose:

  • To evaluate the surgical outcomes of high-risk BDG and TCPC procedures.
  • To assess the feasibility of managing patients with previously contraindicated conditions, including left-sided superior and inferior vena cava anomalies, total anomalous pulmonary venous connection, and severe atrioventricular valve insufficiency.
  • To analyze early and mid-term results in a cohort of patients who underwent these complex surgeries.

Summary:

  • A series of 112 BDG and 93 TCPC procedures were performed between 1994 and 2004.
  • High-risk patients included those with associated anomalies like total anomalous pulmonary venous connection and severe atrioventricular valve insufficiency, with some undergoing complex repairs.
  • Early results demonstrated encouraging outcomes, with improved ventricular function and successful management of previously contraindicated defects, although long-term ventricular function requires further study.

Impact:

  • Demonstrates that high-risk BDG and TCPC operations can be performed with acceptable early results.
  • Expands the surgical options for patients with complex congenital heart disease and previously contraindicated defects.
  • Provides evidence for the feasibility of managing challenging pediatric cardiac cases, with potential for improved long-term outcomes pending further investigation.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...